| 1 |
32062328 | Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway. | 2020 Mar |
1 |
| 2 |
32411755 | Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway. | 2020 Apr |
2 |
| 3 |
33164356 | [Identification of quality markers for Pudilan Xiaoyan Oral Liquid]. | 2020 Sep |
2 |
| 4 |
31872639 | [Study on regulation of NLRP3/SOCS3-TLR4-NF-κB inflammatory pathway by wogonoside to improve hepatic insulin resistance]. | 2019 Oct |
1 |
| 5 |
28774312 | Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer. | 2017 Aug 3 |
3 |
| 6 |
27102438 | Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway. | 2016 Jun 7 |
1 |
| 7 |
25677765 | Wogonoside protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB and NLRP3 inflammasome activation. | 2015 Mar 15 |
1 |